• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

怀孕不会影响健康女性的粪便钙卫蛋白浓度。

Pregnancy does not affect fecal calprotectin concentration in healthy women.

作者信息

Bálint Anita, Berényi Anna, Farkas Klaudia, Pallagi Kunstár Éva, Altorjay Ábel, Csonka Andrea, Krizsán Mária, Szűcs Mónika, Pál Attila, Fábián Anna, Bor Renáta, Milassin Ágnes, Szulcsán Ádám, Mariann Rutka, Szepes Zoltán, Molnár Tamás

机构信息

Department of Medicine, University of Szeged, Szeged, Hungary.

出版信息

Turk J Gastroenterol. 2017 May;28(3):171-175. doi: 10.5152/tjg.2017.16711. Epub 2017 Mar 23.

DOI:10.5152/tjg.2017.16711
PMID:28336498
Abstract

BACKGROUND/AIMS: Noninvasive activity markers are extremely important in conditions, such as pregnancy, when endoscopy is not recommended. The aim of this prospective study was to determine fecal calprotectin (FC) concentrations in healthy non-pregnant and pregnant women and in patients with inflammatory bowel disease (IBD).

MATERIALS AND METHODS

Healthy pregnant and non-pregnant women and patients with active and inactive IBD were prospectively enrolled in this study. Demographic and clinical parameters and clinical disease activity scores in patients with IBD were recorded. Blood and stool samples of every patient were obtained to determine C-reactive protein and FC levels. FC levels were measured with a quantitative lateral flow assay.

RESULTS

One hundred and thirty-five subjects were enrolled in the study (24 non-pregnant and 48 pregnant healthy women, 40 non-pregnant patients with active IBD and 23 non-pregnant patients with inactive IBD). FC was significantly higher in active IBD patients than in pregnant (p<0.001) and non-pregnant healthy women (p<0.001). No difference could be detected in FC concentrations between pregnant and non-pregnant healthy women.

CONCLUSION

Since FC levels remained unchanged during pregnancy, it may be a useful noninvasive diagnostic tool in pregnancy for monitoring mucosal inflammation.

摘要

背景/目的:在诸如妊娠等不建议进行内镜检查的情况下,非侵入性活动标志物极为重要。本前瞻性研究的目的是确定健康非妊娠和妊娠女性以及炎症性肠病(IBD)患者的粪便钙卫蛋白(FC)浓度。

材料与方法

前瞻性纳入健康妊娠和非妊娠女性以及活动期和非活动期IBD患者。记录IBD患者的人口统计学和临床参数以及临床疾病活动评分。采集每位患者的血液和粪便样本以测定C反应蛋白和FC水平。采用定量侧向流动分析法测量FC水平。

结果

135名受试者纳入研究(24名非妊娠健康女性、48名妊娠健康女性、40名活动期非妊娠IBD患者和23名非活动期非妊娠IBD患者)。活动期IBD患者的FC显著高于妊娠健康女性(p<0.001)和非妊娠健康女性(p<0.001)。妊娠健康女性和非妊娠健康女性之间的FC浓度未检测到差异。

结论

由于FC水平在妊娠期间保持不变,它可能是妊娠期间监测黏膜炎症的一种有用的非侵入性诊断工具。

相似文献

1
Pregnancy does not affect fecal calprotectin concentration in healthy women.怀孕不会影响健康女性的粪便钙卫蛋白浓度。
Turk J Gastroenterol. 2017 May;28(3):171-175. doi: 10.5152/tjg.2017.16711. Epub 2017 Mar 23.
2
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.粪便钙卫蛋白不受妊娠影响:对炎症性肠病孕妇管理的临床意义。
Inflamm Bowel Dis. 2017 Jul;23(7):1240-1246. doi: 10.1097/MIB.0000000000001136.
3
Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.孕妇中中重度炎症性肠病患者粪便钙卫蛋白的变化
Inflamm Bowel Dis. 2018 Mar 19;24(4):839-848. doi: 10.1093/ibd/izx055.
4
Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.快速粪便钙卫蛋白检测评估炎症性肠病内镜下疾病活动度:一项诊断队列研究
Saudi J Gastroenterol. 2015 Nov-Dec;21(6):360-6. doi: 10.4103/1319-3767.170948.
5
Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies.孕妇中炎症性肠病患者和非炎症性肠病患者粪便钙卫蛋白水平的纵向变化及其婴儿。
Gastroenterology. 2021 Mar;160(4):1118-1130.e3. doi: 10.1053/j.gastro.2020.11.050. Epub 2020 Dec 9.
6
Fecal calprotectin as a promising marker of inflammatory diseases.粪便钙卫蛋白作为一种有前景的炎症性疾病标志物。
Bratisl Lek Listy. 2009;110(10):598-602.
7
Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.粪便钙卫蛋白作为炎症性肠病患儿黏膜炎症严重程度的标志物。
Wien Klin Wochenschr. 2016 Apr;128(7-8):253-9. doi: 10.1007/s00508-015-0915-3. Epub 2015 Dec 10.
8
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.炎症性肠病中肠道炎症评估的非侵入性标志物:粪便乳铁蛋白、钙卫蛋白、PMN弹性蛋白酶、CRP及临床指标的表现
Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4.
9
Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.快速粪便钙卫蛋白水平评估和炎症性肠病问卷(SIBDQ)评分可准确检测临床缓解期炎症性肠病(IBD)患者的活动性黏膜炎症:一项前瞻性研究。
J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.
10
Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.炎症性肠病患者粪便钙卫蛋白的变异性:一项观察性病例对照研究。
J Crohns Colitis. 2019 Oct 28;13(11):1372-1379. doi: 10.1093/ecco-jcc/jjz069.

引用本文的文献

1
Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy.沙特阿拉伯妊娠期炎症性肠病管理共识指南。
Saudi J Gastroenterol. 2023 Dec 15;30(4):181-97. doi: 10.4103/sjg.sjg_318_23.
2
Optimizing maternal and neonatal outcomes through tight control management of inflammatory bowel disease during pregnancy: a pilot feasibility study.通过在孕期对炎症性肠病进行严格的控制管理来优化母婴结局:一项初步可行性研究。
Sci Rep. 2023 May 22;13(1):8291. doi: 10.1038/s41598-023-35332-z.
3
Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature.
正常妊娠及炎症性肠病期间的粪便乳铁蛋白及其他粪便标志物:一项前瞻性研究及文献综述
Inflamm Intest Dis. 2020 Aug;5(3):151-157. doi: 10.1159/000508970. Epub 2020 Jul 1.
4
Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.粪便钙卫蛋白可能预测炎症性肠病患者与妊娠相关的不良结局。
Dig Dis Sci. 2021 May;66(5):1639-1649. doi: 10.1007/s10620-020-06381-5. Epub 2020 Jun 12.
5
The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study.母婴参数对健康新生儿出生后七天内血液和粪便中zonulin和钙卫蛋白浓度的影响。一项观察性前瞻性队列研究。
J Clin Med. 2019 Apr 7;8(4):473. doi: 10.3390/jcm8040473.
6
Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know?孕期的胃肠道疾病:胃肠病学家需要了解什么?
Ann Gastroenterol. 2018 Jul-Aug;31(4):385-394. doi: 10.20524/aog.2018.0264. Epub 2018 Apr 27.
7
Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges.孕期炎症性肠病的监测:当前文献与未来挑战
World J Gastrointest Pharmacol Ther. 2018 Feb 6;9(1):1-7. doi: 10.4292/wjgpt.v9.i1.1.